Vox Markets Logo
1st November 2024
07:00

N4 Pharma PLC - N4 Pharma CEO Q&A Now LIVE

24th October 2024
06:00

N4 Pharma PLC - New Corporate Presentation

24th September 2024
06:00

N4 Pharma PLC - Interim Results

17th September 2024
07:04

N4 Pharma PLC - SRI Research Update

9th September 2024
06:00

N4 Pharma PLC - Director Appointment

23rd August 2024
07:30

N4 Pharma PLC - Change of Auditor

20th August 2024
06:00

N4 Pharma PLC - SRI Research Update

3rd July 2024
06:00

N4 Pharma PLC - Nanogenics Update

28th June 2024
06:00

N4 Pharma PLC - Total Voting Rights

19th June 2024
06:00

N4 Pharma PLC - Holding(s) in Company

18th June 2024
11:34

N4 Pharma PLC - Holding(s) in Company

13th June 2024
15:52

N4 Pharma PLC - Holding(s) in Company

11th June 2024
10:16

N4 Pharma PLC - New Corporate Presentation

7th June 2024
09:18

N4 Pharma PLC - Placing and Subscription to raise £630,000

23rd May 2024
15:09

N4 Pharma PLC - Holding(s) in Company

23rd May 2024
11:19

N4 Pharma PLC - Result of AGM

29th April 2024
09:59

N4 Pharma PLC - Posting of Annual Report & Notice of AGM

26th April 2024
06:00

N4 Pharma PLC - N4 Pharma Webinar on SRI Collaboration

N4 Pharma Plc (N4P.L) Share Price & News


Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -M
  • LOW
    -
  • CLOSE
    -
  • SHARES IN ISSUE
    268.78M

N4 Pharma Plc Company Profile

We’re N4 Pharma, a specialist pharmaceutical company developing a novel silica nanoparticle delivery system for vaccines and therapeutics for licensing to pharmaceutical and biotech partners. This nanoparticle has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines.

Watchlist